Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 3, 1998, Pages 840-845

  Lutz, Charles ^b   Carney, David ^b   Finck, Christine ^b   Picone, Anthony ^b   Gatto, Louis A ^b   Paskanik, Andrew ^b   Langenback, Edward ^b   Nieman, Gary ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HEMODYNAMIC PARAMETERS; HISTOMETRY; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; LUNG INJURY; NONHUMAN; OXYGENATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SWINE;

EID: 0031750698     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.3.9801089     Document Type: Article

References (33)

1. Zeni, F., B. Freeman, and C. Natanson. 1997. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit. Care Med. 25:1095-1100.
2. Ashbaugh, D. G., D. B. Bigelow, T. L. Petty, and B. E. Levine. 1967. Acute respiratory distress in adults. Lancet 2:319-323.
3. Petty, T. L., G. W. Silvers, G. W. Paul, and R. E. Stanford. 1979. Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 75:571-574.
4. Gregory, T., W. Longmore, M. Moxley, J. Whitsett, C. Reed, A. Fowler, L. Hudson, and R. Maunder, C. Crim, and T. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 65:1976-1981.
5. Seeger, W., G. Stöhr, W. R. D. Wolf, and H. Neuhof. 1985. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J. Appl. Physiol. 56:326-338.
6. O2 in mature rabbits with lungs that contain large amounts of saline. Am. Rev. Respir. Dis. 147:1087-1090.
7. Gommers, D., C. Vilstrup, J. A. H. Bos, A. Larsson, O. Werner, E. Hannappel, and B. Lachman. 1993. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Crit. Care Med. 21:567-574.
8. Lewis, J. F., B. Tabor, M. Ikegami, A. H. Jobe, M. Joseph, and D. Absolom. 1993. Lung function and surfactant distribution in saline-lavaged sheep given instilled vs nebulized surfactant. J. Appl. Physiol. 74:1256-1264.
9. Kobayashi, T., H. Kataoka, T. Ueda, S. Murakami, Y. Takada, and M. Kokubo. 1984. Effects of surfactant supplement and end-expiratory pressure in lung-lavaged rabbits. J. Appl. Physiol. 57:995-1001.
10. Huang, Y. T., S. P. Caminiti, T. A. Fawcett, R. E. Moon, P. J. Fracica, F. J. Miller, S. L. Young, and C. Piantadosi. 1994. Natural surfactant and hyperoxic lung injury in primates: I. Physiology and biochemistry. J. Appl. Physiol. 76:991-1001.
11. Lamm, W. J. E., and R. K. Albert. 1990. Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am. Rev. Respir. Dis. 142:1279-1283.
12. Zelter, M., B. J. Escudier, J. M. Hoeffel, and J. F. Murray. 1990. Effects of aerosolized artificial surfactant on repeated oleic acid injury in sheep. Am. Rev. Respir. Dis. 141:1014-1019.
13. Tashiro, K., K. Yamada, W. Z. Li, Y. Matsumoto, and T. Kobayashi. 1996. Aerosolized and instilled surfactant therapies for acute lung injury caused by intratracheal endotoxin in rats. Crit. Care Med. 24:488-494.
14. Anzueto, A., R. P. Baughman, K. K. Guntupalli, J. G. Weg, H. P. Wiedemann, A. A. Raventos, F. Lemaire, W. Long, D. S. Zaccardelli, and E. N. Pattishall. 1996. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N. Engl. J. Med. 334: 1417-1421.
15. Weg, J. G., R. A. Balk, S. Tharratt, S. G. Jenkinson, J. B. Shah, D. Zaccardelli, J. Horton, and E. N. Pattishall. 1994. Safety and potential efficacy of an aerosolized surfactant in human sepsis induced adult respiratory distress syndrome. J.A.M.A. 272:1433-1438.
16. Gregory, T. J., K. P. Steinberg, R. Spragg, J. E. Gadek, T. M. Hyers, W. J. Longmore, M. A. Moxley, G.-Z. Cai, P. Newton, B. R. Mitchell, and A. J. Gold. 1997. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1309-1315.
17. Picone, A., L. A. Gatto, G. F. Nieman, A. M. Paskanik, and C. Lutz. 1996. Pulmonary surfactant function following endotoxin: effects of exogenous surfactant treatment. Shock 5:304-310.
18. Lutz, C., A. Picone, L. A. Gatto, A. Paskanik, S. Landas, and G. Nieman. 1998. Exogenous surfactant and positive end-expiratory pressure (PEEP) in the treatment of endotoxin induced lung injury. Crit. Care Med. (In press)
19. Fink, M. P., B. P. O'Sullivan, M. J. Menconi, P. S. Wollert, H. Wang, M. E. Youssrf, and J. H. Fleisch. 1993. A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective controlled trial in a porcine model. Crit. Care Med. 21:1825-1837.
20. Cummings, J. J., B. A. Holm, M. L. Hudak, B. B. Hudak, W. H. Ferguson, and E. A. Eagan. 1992. A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. Am. Rev. Respir. Dis. 145:999-1004.
21. Barry, B. E., and J. D. Crapo. 1985. Application of morphometric methods to study diffuse and focal injury in the lung caused by toxic agents. Crit. Rev. Toxicol. 14:1-32.
22. Gundersen, H. G. J. 1997. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111:219.
23. Zeger, S. L., and K. Y. Liang. 1992. An overview of methods for the analysis of longitudinal data. Stat. Med. 11:1825-1839.
24. Engstrom, P. C., B. A. Holm, and S. Matalon. 1989. Surfactant replacement attenuates the increase in alveolar permeability in hypoxia. J. Appl. Physiol. 67:688-693.
25. Harris, J. D., F. Jackson, M. A. Moxley, and W. J. Longmore. 1989. Effect of exogenous surfactant instillation on experimental acute lung injury. J. Appl. Physiol. 66:1846-1851.
26. Scarpelli, E. M., E. David, M. Cordova, and A. J. Mautone. 1993. Surface tension of therapeutic surfactant (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods criteria. Am. J. Perinatol. 10:414-419.
27. MacIntyre, N. R., R. E. Coleman, F. S. Schuller, D. Zaccardelli, and E. Pattishall. 1994. Efficiency of the delivery of aerosolized artificial surfactant in intubated patients with the adult respiratory distress syndrome (abstract). Am. J. Respir. Crit. Care Med. 149:A125.
28. Vincent, J. L. 1997. Dear SIRS, I'm sorry to say that I don't like you. . . . Crit. Care Med. 25:372-374.
29. Nieman, G. F., L. A. Gatto, A. M. Paskanik, B. Yang, R. Fluck, and A. Picone. 1996. Surfactant replacement in the treatment of sepsis induced adult respiratory distress syndrome (ARDS) in pigs. Crit. Care Med. 24:1025-1033.
30. Kawano, T., S. Mori, M. Cybulsky, R. Burger, A. Ballin, B. Cutz, and A. C. Bryan. 1987. Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J. Appl. Physiol. 62:27-33.
31. Thomassen, M. J., J. M. Antal, M. J. Conners, D. P. Meeker, and H. P. Wiedemann. 1994. Characterization of Exosurf(surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses. Am. J. Respir. Cell Mol. Biol. 10:399-404.
32. Antal, J. M., L. T. Davis, S. C. Erzurum, H. P. Wiedemann, and M. J. Thomassen. 1996. Surfactant suppresses NF-kappa B activation in human monocyte cells. Am. J. Respir. Cell Mol. Biol. 14:374-379.
33. Finck, C. M., M. G. Hodell, W. H. Marx, A. M. Paskanik, D. J. McGraw, C. J. Lutz, L. A. Gatto, A. L. Picone, and G. F. Nieman. 1998. Endotoxin stimulated alveolar macrophage recruitment of neutrophils and modulation with exogenous surfactant. Crit. Care Med. (In press)